SANOFI PASTEUR

In a randomized controlled trial, Fluzone High-Dose (Influenza Vaccine) trivalent formulation provided 24% (95% CI: 10-37) better protection against influenza due to any lab-confirmed circulating strains vs a standard-dose influenza vaccine in adults 65 years of age and older. 2,8... Sanofi offers a range of trivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype type B virus. Please see Important Safety Information or Prescribing Information.

Also known as: Protein Sciences Corporation, Sanofi Pasteur Inc